Channing Der

Company: UNC Chapel Hill

Job title: Sarah Graham Kenan Distinguished Professor

Seminars:

Revolutionizing Cancer Treatment: Unleashing the Power of RAS-Targeted Drugs in 2023 & Beyond 5:00 pm

Highlighting past successes and preparing for future challenges in RAS-targeted drug development to keep you up-to-date on the latest trends in cancer treatment Exploring innovative research avenues for targeting oncogenic RAS using emerging approaches, providing insights into cutting-edge techniques for developing more effective treatments Assessing clinical developments and setting actionable goals to rapidly advance RAS-targeted…Read more

day: Conference Day Two

RAS 101: Understanding the RAS Pathway & Its Oncogenic Mutations to Improve Drug Discovery & Design 9:01 am

The RAS/MAPK pathway is an extremely important signalling cascade that plays a major role in driving oncogenesis. It stretches from receptors on the cell membrane to transcription factors in the nucleus and is naturally robust to prevent disruption. Hence, to effectively target RAS and its surrounding molecules for effective cancer therapy, it is important to…Read more

day: Workshop A